Skip to main content
. 2022 Oct 21;25(Suppl 6):e26009. doi: 10.1002/jia2.26009
Abstract P236 – Table 1. Summary of patient characteristics at ICU admission.
Characteristic, n (%) or median (interquartile range) Overall n=207 Not diagnosed late n=149 Diagnosed late n=149 p‐value
Demographic factors
Age (years) 46 (38‐53) 46 (40‐54) 44 (36‐52) 0.11
Male (sex at birth) 148 (71.5%) 110 (73.8%) 38 (65.5%) 0.23
Clinical factors
Acute Physiology and Chronic Health Evaluation II score 19 (14‐25) 19 (13‐25) 21 (14‐26) 0.28
Advanced HIVa 138 (67.3%) 83 (56.5%) 55 (94.8%) <0.001
Undetectable (viral load ≤50 copies/mL) 90 (45.0%) 85 (58.2%) 5 (9.3%) <0.001
CD4+ T‐cell count <350 cells/mm3 at admission 164 (80.4%) 106 (72.6%) 58 (100.0%) <0.001
Receipt of combination antiretroviral therapy (cART)b 147 (73.5%) 129 (88.4%) 18 (33.3%) <0.001
Primary diagnosis at admission category
Cardiovascular 7 (3.4%) 6 (4.0%) 1 (1.7%) 0.14
Gastrointestinal 23 (11.1%) 18 (12.1%) 5 (8.6%)
Infection 27 (13.0%) 18 (12.1%) 9 (15.5%)
Lower respiratory tract infection 65 (31.4%) 43 (28.9%) 22 (37.9%)
Neurological 20 (9.7%) 12 (8.1%) 8 (13.8%)
Oncological/Haematological 18 (8.7%) 11 (7.4%) 7 (12.1%)
Renal 12 (5.8%) 10 (6.7%) 2 (3.4%)
Other 35 (16.9%) 31 (20.8%) 4 (6.9%)

aCD4+ T‐cell count <200 cells/mm and/or an AIDS‐defining illness at admission;

bpatients were considered to be receiving cART if they had (1) data on cART start date pre‐dating ICU admission; or (2) a VL <1000 copies/mL at ICU admission but no cART date, as it was considered unlikely these patients exhibiting viraemic control were not on any form of cART.